Harvard Pilgrim Health Care Home
  HPHConnect
 
  Learn more.
  Sign up for HPHConnect.
Medical Management
E-Transactions
HPHConnect
Pharmacy
For Your Patient
News Center
Network Matters
Newsletter Archives
Newsletter Registration
Newsroom
Office Support
Products
Provider Manual
Medicare Advantage
Research & Teaching
Resources & Links
 
Print    Text Size

Network Matters
News and Information for the
Harvard Pilgrim Health Care Network

October 2014

P&T Committee Updates 


At the Sept. 8, 2014 meeting, the Harvard Pilgrim Pharmacy & Therapeutics Committee reviewed two medications and decided the following.

P&T Committee Review and Decisions

Name

Indication

Decision

Anoro Ellipta (umeclidinium and vilanterol inhalation powder)

Anoro Ellipta— a combination anticholinergic and long-acting beta2 agonist — is used for long-term maintenance treatment of airflow obstruction, such as bronchitis and/or emphysema, in patients with chronic obstructive pulmonary disease (COPD).  Anoro is taken by inhaling the medication through the Ellipta device. 

Commercial products

Continued coverage at:

• Tier 3 for 3-Tier formulary
• Tier 4 for 4-Tier formulary

Medicare Advantage products

Continued coverage at Tier 3 (4-Tier formulary)

Tudorza Pressair
(aclidinium bromide)  

Tudorza is an anticholinergic used for long-term maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD). Tudorza is taken by inhaling the medication through the Pressair device.  

Commercial products
Moved to:

• Tier 2 for 3-Tier formulary
• Tier 3 for 4-Tier formulary

Medicare Advantage products
Continued coverage at Tier 3 (4-Tier formulary)

Email this article to a colleague   


Network Matters Archives

Download printer-friendly version

HPHCURRENT EVENTS

How Are We Doing? Tell Us!

New Medicare Advantage Products in 2015

New NH Limited Network Products Offered January 1

Register for the Mindfulness Conference

CLINICIAN CORNER

Value Formulary Offered in 2015

Payment Policy Update: Magnetic Resonance Spectroscopy

Reminder: Synagis for Upcoming RSV Season

P&T Committee Updates

ADHD Diagnosis and Follow-up Care

OFFICE ASSISTANT

2015 CPT and HCPCS codes

PUBLICATION INFORMATION

Eric H. Schultz,
President and Chief Executive Officer

Richard Weisblatt PhD,
Senior Vice President, Provider Network

Annmarie Dadoly,
Editor

Kristin Edmonston,
Production Coordinator